KCNQ2 and epilepsy: Retigabine, the anticonvulsant that works by negative-shifting the voltage dependence of KCNQ2/3 channel activation, is effective in forms of epilepsy not caused by KCNQ2/3 channel dysfunction, as well as those that are74.